spacer
home > ebr > winter 2009 > streamlining processes
PUBLICATIONS
European Biopharmaceutical Review

Streamlining Processes

Procurement officers, lab managers and CFOs at pharmaceutical and biopharmaceutical companies are under tremendous pressure to improve internal processes, outsource internal functions and focus on suppliers’ costs. They have traditionally relied on original equipment manufacturers (OEMs) to maintain their vast and diverse range of laboratory equipment and inventories. This is fine if there are only a small number of assets, but the majority of biopharmaceutical companies have hundreds of assets, each requiring individual maintenance contracts.

Furthermore, there are a number of disadvantages to this model, including the administrative burden on employees (and hence the detraction from normal work), and the time it takes to manage vast inventories, which can divert resources away from core scientific projects.

One way to improve asset management efficiency and drive down costs is to use an external multi-vendor asset management service to maintain all laboratory equipment and inventory. Such third-party service providers can offer a wide range of services, including:


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Bob Moore is the North American Service Sales Director for GE Healthcare’s Life Sciences business. Bob started his career with GE in 1986. His vast service experience with GE Healthcare began as a field engineer, and he has spent the last few years in developing and marketing GE’s service offerings and business solutions for the life science markets. Bob holds a BS EET degree from DeVry Technical Institute in Chicago, IL. Bob has also received extensive leadership training at the John F. Welch Leadership Training Center in Crotonville, NY.
spacer
Bob Moore
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

International Research Coalition Verifies Safe Surgical Access to the Central Core of the Human Cochlea for the Very First Time

SHEFFIELD, UK, 8 November 2022: An international team of surgeons and scientists has, for the first time, validated safe surgical access to the central core of the human cochlea in a study funded by Rinri Therapeutics, a biotechnology company developing regenerative cell therapies for sensorineural hearing loss (SNHL).
More info >>

White Papers

ECCRT

ECCRT

The European Centre for Clinical Research Training (ECCRT) is a professional clinical research training provider focusing on the transfer of implementable knowledge for the day-to-day activities of our participants whether being new to the industry, starters on the job, or seasoned professionals. Our mission is to facilitate Clinical Research professionals to excel in their job for the benefit of patients. We aim to achieve this by providing clinical research professionals with competencies to develop new therapies for patients quicker & more efficiently, without jeopardizing quality and safety.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement